Perceptions, Practices and Barriers to Reporting of Adverse Drug Reactions Among HIV Infected Patients and Their Doctors in 3 Public Sector Hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a Cross Sectional and Retrospective Analysis

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2022 Aug 18

PMID 35982442

Authors

Sindiswa Zondi

Panjasaram Naidoo

Affiliations

Soon will be listed here.

Abstract

Background: Adverse drug reactions (ADRs) remain a global public health concern. Pharmacovigilance practises are essential in ensuring patients safety and post drug marketing surveillance. This study aimed to describe practices, perceptions and barriers towards ADR reporting practices amongst People Living with HIV/AIDS (PLWHA), who are on Highly Active Anti-Retroviral Therapy (HAART) and their doctors.

Methods: The study took place at 3 public sector hospitals. The first phase of the study was a quantitative cross-sectional study using a closed ended questionnaire that was given to PLWHA. Phase two was a retrospective analysis of these patients' medical files, whilst phase 3 included a descriptive statistics to determine the frequencies and percentages for variables such as ADR reporting practices by doctors.

Results: Spontaneous reporting, was evident with 202 patients (48%) indicating that they reported experiencing ADRs to their doctors. Ten doctors (77%) indicated that they received PV training. Eight (62%) doctors indicated that the completed ADR reporting forms were submitted to the pharmacy manager in the hospital for forwarding to the regulatory authority, with 2 (15%) indicating that they submitted directly to the South African Health Products Regulatory Authority. Four (31%) doctors stated that the system of reporting ADRs is ineffective with the majority of the doctors 12 (92%) responding that the reporting of ADRs is very important/critical. A barrier cited by 4 patients (0.9%) for non-reporting of their ADRs was transport cost. Whilst doctors' barriers included reporting being time consuming (31%), and a lack of availability of reporting forms (31%).

Conclusion: Patients and doctors are reporting ADRs but more education and easier reporting process should be available to strengthen the knowledge and reporting of ADRs. Doctors agree that it is critical to report ADRs. Electronic reporting should be encouraged to lessen the time it takes to report ADRs.

Citing Articles

Improving ADR reporting in Jordan: a qualitative exploration of pharmacists' perspectives.

Suleiman A Front Med (Lausanne). 2025; 11():1513611.

PMID: 39835106 PMC: 11743529. DOI: 10.3389/fmed.2024.1513611.

Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study.

Shareef J, Sridhar S, Bhupathyraaj M, Shariff A, Thomas S Ther Adv Drug Saf. 2024; 15:20420986241285930.

PMID: 39381061 PMC: 11459486. DOI: 10.1177/20420986241285930.

A Case Report on Clotrimazole-Induced Localized Erythema.

Sarma I, Ray N, Banerjee P, Das S, Brahma D Cureus. 2024; 16(1):e52682.

PMID: 38264180 PMC: 10804214. DOI: 10.7759/cureus.52682.

References

Li R, Curtain C, Bereznicki L, Zaidi S . Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm. 2018; 40(4):878-889. PMC: 6132965. DOI: 10.1007/s11096-018-0700-2. View

Kiguba R, Karamagi C, Waako P, Ndagije H, Bird S . Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants. BMJ Open. 2014; 4(11):e005869. PMC: 4244492. DOI: 10.1136/bmjopen-2014-005869. View

Elkalmi R, Hassali M, Al-Lela O, Jawad Awadh A, Al-Shami A, Jamshed S . Adverse drug reactions reporting : Knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci. 2013; 5(3):224-8. PMC: 3778592. DOI: 10.4103/0975-7406.116824. View

Abah I, Ncube N, Bradley H, Agbaji O, Kanki P . Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria. Curr HIV Res. 2019; 16(6):436-446. PMC: 6446442. DOI: 10.2174/1389450120666190214144609. View

Upadhyaya H, Vora M, Nagar J, Patel P . Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat. J Adv Pharm Technol Res. 2015; 6(1):29-34. PMC: 4330609. DOI: 10.4103/2231-4040.150369. View

Ampadu H, Hoekman J, de Bruin M, Pal S, Olsson S, Sartori D . Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. Drug Saf. 2016; 39(4):335-45. PMC: 4796322. DOI: 10.1007/s40264-015-0387-4. View

Layton D, Shakir S . Specialist Cohort Event Monitoring studies: a new study method for risk management in pharmacovigilance. Drug Saf. 2015; 38(2):153-63. PMC: 4328122. DOI: 10.1007/s40264-014-0260-x. View

Hardeep , Bajaj J, Rakesh K . A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India. J Clin Diagn Res. 2013; 7(1):97-9. PMC: 3576761. DOI: 10.7860/JCDR/2012/4883.2680. View

Mehta U, Kalk E, Boulle A, Nkambule P, Gouws J, Rees H . Pharmacovigilance: A public health priority for South Africa. S Afr Health Rev. 2017; 2017:125-133. PMC: 5708547. View

10.

Babb D, Pemba L, Seatlanyane P, Charalambous S, Churchyard G, Grant A . Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy. Psychol Health Med. 2007; 12(3):314-20. DOI: 10.1080/13548500600621511. View

11.

Rachlis B, Karwa R, Chema C, Pastakia S, Olsson S, Wools-Kaloustian K . Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf. 2016; 39(10):959-76. PMC: 5018020. DOI: 10.1007/s40264-016-0434-9. View

12.

Ruud K, Srinivas S, Toverud E . Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa. Res Social Adm Pharm. 2010; 6(4):345-53. DOI: 10.1016/j.sapharm.2009.11.006. View

13.

Arnott J, Hesselgreaves H, Nunn A, Peak M, Pirmohamed M, Smyth R . What can we learn from parents about enhancing participation in pharmacovigilance?. Br J Clin Pharmacol. 2012; 75(4):1109-17. PMC: 3612729. DOI: 10.1111/j.1365-2125.2012.04441.x. View

14.

Khan T . Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther Adv Drug Saf. 2014; 4(2):45-51. PMC: 4110832. DOI: 10.1177/2042098612474292. View

15.

Edwards I, Aronson J . Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000; 356(9237):1255-9. DOI: 10.1016/S0140-6736(00)02799-9. View

16.

Abdel-Latif M, Abdel-Wahab B . Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015; 23(2):154-61. PMC: 4420988. DOI: 10.1016/j.jsps.2014.07.005. View

17.

Motheral B, Brooks J, Clark M, Crown W, Davey P, Hutchins D . A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases. Value Health. 2003; 6(2):90-7. DOI: 10.1046/j.1524-4733.2003.00242.x. View

18.

Oscanoa T, Lizaraso F, Carvajal A . Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017; 73(6):759-770. DOI: 10.1007/s00228-017-2225-3. View

19.

Ganesan S, Sandhiya S, Reddy K, Subrahmanyam D, Adithan C . The Impact of the Educational Intervention on Knowledge, Attitude, and Practice of Pharmacovigilance toward Adverse Drug Reactions Reporting among Health-care Professionals in a Tertiary Care Hospital in South India. J Nat Sci Biol Med. 2017; 8(2):203-209. PMC: 5523529. DOI: 10.4103/0976-9668.210014. View

20.

Gupta S, Nayak R, Shivaranjani R, Vidyarthi S . A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015; 6(1):45-52. PMC: 4314847. DOI: 10.4103/2229-3485.148816. View